Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Verve Therapeutics Inc (VERV)

Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
After a Serious Setback, Is Verve Therapeutics a Buy?

There are a few silver linings at play here.

VERV : 6.41 (+4.23%)
Stocks Close Lower on Fears Fed Rate Cuts Will be Delayed

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.94%. Stock indexes...

$SPX : 5,127.79 (+1.26%)
SPY : 511.29 (+1.24%)
$DOWI : 38,675.68 (+1.18%)
DIA : 386.77 (+1.19%)
$IUXX : 17,890.80 (+1.99%)
QQQ : 435.48 (+2.01%)
^BTCUSD : 63,701.73 (+1.33%)
ZNM24 : 108-275s (+0.46%)
HUM : 320.54 (-0.14%)
CVS : 55.90 (+1.36%)
UNH : 492.45 (-0.11%)
CNC : 74.81 (+0.65%)
Stocks Fall as Bond Yields Climb on Strong US Economic News

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.51%. Stock indexes this...

$SPX : 5,127.79 (+1.26%)
SPY : 511.29 (+1.24%)
$DOWI : 38,675.68 (+1.18%)
DIA : 386.77 (+1.19%)
$IUXX : 17,890.80 (+1.99%)
QQQ : 435.48 (+2.01%)
^BTCUSD : 63,701.73 (+1.33%)
ZNM24 : 108-275s (+0.46%)
HUM : 320.54 (-0.14%)
CVS : 55.90 (+1.36%)
UNH : 492.45 (-0.11%)
CNC : 74.81 (+0.65%)
Stocks Retreat as Bond Yields Jump on Diminished Fed Rate Cut Prospects

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.47%. Stock indexes this...

$SPX : 5,127.79 (+1.26%)
SPY : 511.29 (+1.24%)
$DOWI : 38,675.68 (+1.18%)
DIA : 386.77 (+1.19%)
$IUXX : 17,890.80 (+1.99%)
QQQ : 435.48 (+2.01%)
ZNM24 : 108-275s (+0.46%)
HUM : 320.54 (-0.14%)
CVS : 55.90 (+1.36%)
UNH : 492.45 (-0.11%)
ELV : 526.96 (+0.26%)
CNC : 74.81 (+0.65%)
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare

It's less scary to take on risky investments when the market is rising.

CRBU : 3.77 (+3.57%)
VERV : 6.41 (+4.23%)
Why Beam Therapeutics Stock Zoomed 17% Higher Today

JPMorgan Chase becomes the latest institution in the company's bull pen.

VERV : 6.41 (+4.23%)
LLY : 734.97 (-2.77%)
BEAM : 23.13 (+1.80%)
JPM : 190.51 (-0.60%)
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics

Curing rare inherited illnesses could be a lucrative business model.

CRSP : 55.89 (+1.49%)
NTLA : 23.60 (+1.42%)
VERV : 6.41 (+4.23%)
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.

The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.

CRSP : 55.89 (+1.49%)
BEAM : 23.13 (+1.80%)
CRBU : 3.77 (+3.57%)
EDIT : 5.67 (+0.89%)
NTLA : 23.60 (+1.42%)
PRME : 5.59 (-0.36%)
VERV : 6.41 (+4.23%)
LLY : 734.97 (-2.77%)
REGN : 957.00 (+2.07%)
VRTX : 401.08 (+0.23%)
ARKG : 25.04 (+3.51%)
HOOD : 17.95 (+1.93%)
Why Verve Therapeutics Stock Crashed as Much as 30% This Week

There was a concerning development in the company's clinical trials.

VERV : 6.41 (+4.23%)
Verve Therapeutics: Why Great Results Aren't Enough

The company's twist on CRISPR appears to work as intended but that didn't stop this biotech's stock price from collapsing.

VERV : 6.41 (+4.23%)

Barchart Exclusives

2 Uranium Stocks With 50% or More Upside Potential
As U.S. passes the bill to ban uranium import from Russia, U.S. based uranium companies are sure to enjoy the increased demand. Here are 2 stocks with upside according to analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar